COMBIFOR

COMBIFOR

DCI : BUDESONIDE+FORMOTEROL

Dosage 400 mcg/12 mcg
Pharmaceutical form Powder for oral inhalation
Therapeutic class Pneumology
B/120 capsules
Indications

1- Asthma: Combifor is indicated for the continuous treatment of persistent asthma, in situations where the inhaled administration of a drug combining a corticosteroid and a long-acting beta-2 agonist bronchodilator is justified: - in patients inadequately controlled by inhaled corticosteroid therapy and taking a short-acting beta-2 agonist bronchodilator by inhalation on demand or - in patients controlled by administration of inhaled corticosteroid therapy in combination with continuous treatment with long-acting inhaled beta-2 agonist.

2- Chronic obstructive pulmonary disease (COPD) Symptomatic treatment of severe COPD (FEV <50% of the theoretical value) in patients with a history of repeated exacerbations and significant symptoms despite continuous treatment with a long-acting bronchodilator .

Download the leaflet

Similar Products

AEROFOR
AEROFOR
AEROFOR
AEROFOR
AERONIDE
AERONIDE
AERONIDE
AERONIDE
COMBIFOR
COMBIFOR
MUXOL 
MUXOL 
MUXOL FORT 
MUXOL FORT 
PAXELADINE 
PAXELADINE 
RHUVEX ADULTE TOUX SECHE
RHUVEX ADULTE TOUX SECHE
RHUVEX ENFANTS TOUX SECHE
RHUVEX ENFANTS TOUX SECHE